Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Newsletter Article
|
BioCardia's Heart Failure Cell Therapy Shows 100% Survival At Two YearsBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
22 |
Material Type: Newsletter Article
|
AstraZeneca Touts Positive Farxiga Data, Seeks Label Expansion In Heart FailureBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
23 |
Material Type: Newsletter Article
|
Emperor emeritus of Japan recovering after heart failure diagnosisCE Noticias Financieras, 2022CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
24 |
Material Type: Newsletter Article
|
Emperor emeritus Akihito recovering from heart failureCE Noticias Financieras, 2022CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
25 |
Material Type: Newsletter Article
|
‘Miracle boy’ returns home after year in hospitalPress Association, 2022Copyright Press Association Limited Jun 21, 2022Digital Resources/Online E-Resources |
|
26 |
Material Type: Newsletter Article
|
Press Release: Bayer to Present Investigational -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 10, 2024Digital Resources/Online E-Resources |
|
27 |
Material Type: Newsletter Article
|
CVRx Reports First Quarter 2024 Financial and Operating ResultsNews Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 1, 2024Digital Resources/Online E-Resources |
|
28 |
Material Type: Newsletter Article
|
The Spanish calculator capable of knowing the risk of death from heart failureCE Noticias Financieras, 2022CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
29 |
Material Type: Newsletter Article
|
Windtree Reveals Encouraging Data From Istaroxime Study In Early Cardiogenic ShockBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
30 |
Material Type: Newsletter Article
|
26-year-old soccer player dies after suffering heart failure on fieldCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
31 |
Material Type: Newsletter Article
|
Mattia Giani, 26-year-old soccer player, died after suffering heart failure in the fieldCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
32 |
Material Type: Newsletter Article
|
26-year-old semi-professional soccer player dies after suffering heart failure on fieldCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
33 |
Material Type: Newsletter Article
|
Clinical Trial: Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent SystemUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 11, 2024Digital Resources/Online E-Resources |
|
34 |
Material Type: Newsletter Article
|
Vape users are 19% more likely to suffer heart failureCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
35 |
Material Type: Newsletter Article
|
Clinical Trial: Intracellular Magnesium and Heart FailureUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 9, 2024Digital Resources/Online E-Resources |
|
36 |
Material Type: Newsletter Article
|
Man dies of heart failure in Tlalpan centerCE Noticias Financieras, 2022CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
37 |
Material Type: Newsletter Article
|
Hippo Pathway Deficiency Reverses Systolic Heart Failure Post-InfarctionTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
|
38 |
Material Type: Newsletter Article
|
Clinical Trial: FAiling HearT in the Elderly (FATE) StudyUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 2, 2024Digital Resources/Online E-Resources |
|
39 |
Material Type: Newsletter Article
|
Clinical Trial: Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in GermanyUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Mar 28, 2024Digital Resources/Online E-Resources |
|
40 |
Material Type: Newsletter Article
|
Lexicon Announces Loan Facility Of $150M With Oxford Finance To Support Sotagliflozin CommercializationBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |